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“No-reflow” and its mild versions, “slow flow” and “sluggish
flow,” are vexing and potentially severe complications of
percutaneous coronary interventions (PCIs)—vexing be-
cause this inadequate myocardial perfusion is almost unpre-
dictable, difficult to prevent, and occurs in the absence of
angiographic evidence of any epicardial obstacle, thus giving
the operator a sense of powerlessness; severe because a low
“Thrombolysis In Myocardial Infarction” flow grade after
primary PCI for ST-segment elevation myocardial infarc-
tion is associated with a poor clinical outcome (1).
See page 636
Few data are available concerning this phenomenon when
it occurs in stable patients undergoing elective stenting in
native coronary arteries. In this issue of JACC: Cardiovas-
cular Interventions, Kodama et al. (2) compared the plaque
characteristics as defined by computed tomography angiog-
raphy (CTA) as well as clinical outcome in 40 patients with
stable coronary artery disease in whom an elective PCI was
complicated by “slow flow,” with 40 patients in whom this
complication did not occur. The presence of circumferential
calcium in the vicinity of a soft plaque was observed on
CTA in almost two-thirds of patients who developed “slow
flow” associated with transient ischemia. What we do not
know is how often this CTA finding is present in the
general population of stable patients scheduled for elective
PCI. Therefore, the overall specificity of this plaque char-
acteristic as revealed by CTA seems weak. Moreover, given
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he contents of this paper to disclose.the absence of accepted preventive measures to avoid the
“slow flow” phenomenon (3), and given the relatively
favorable outcome of patients in whom this phenomenon
occurred in the Kodama et al. (2) study, it is unlikely that
the discovery of soft plaque with a ring of calcium will
change the treatment strategy of the individual patient.
Several aspects of the “slow flow” phenomenon are
different when it occurs in stable patients undergoing
elective PCI compared with when it happens during pri-
mary PCI. The Kodama et al. (2) data suggest that, in stable
patients, the presence of circumferential calcium deposits
next to a soft plaque is an ideal substrate to induce “slow
flow.” When squeezed between the noncompliant calcium
ring and the inflated balloon catheter, the atherosclerotic
material has no escape other than the longitudinal axis of
the vessel with protrusion into the luminal space. In
addition to making intuitive sense, the data corroborate the
idea that plaque embolization is the main mechanism
leading to “slow flow” in stable patients. However, in
patients with ST-segment elevation myocardial infarction,
on top of embolization of thrombus and plaque material,
ischemia-reperfusion injury is key to the pathophysiology of
“no-reflow.” The duration and extent of ischemia and of
subsequent reperfusion injury as well as the susceptibility of
the microcirculation to injury are responsible for profound
and long-lasting disturbance of the vasoregulation pathways
(4). The latter mechanisms are not present during elective
PCI. These differences in pathophysiological mechanisms
might explain—at least in part—the differences in clinical
consequences of this phenomenon. Although “no-reflow” is
known to be associated with increased mortality when it
complicates primary PCI, patients with stable coronary
artery disease and “slow flow” after PCI reported by
Kodama et al. (2) did relatively well: only 3 developed
limited myocardial necrosis, and there were no deaths at 30
days. In the patients described by Kodama et al. (2), “slow
flow” was well-defined and was associated with objective
and persistent signs of profound ischemia. Thus there is
little doubt that low tissue perfusion was present in these
patients. Fortunately, this complication is relatively rare in
elective PCI. “Sluggish flow”—another term in interven-
tionalist jargon—however, is relatively common after stent-
ing. It is characterized by a lower flow velocity of blood and
contrast in the epicardial artery not associated with signs of
ischemia. This phenomenon is not necessarily associated
with a poor prognosis and might also be based, to a limited
degree, on the process of embolization. Yet, an alternative
explanation to this “sluggish flow” resides in the acute
changes in diameter of the epicardial artery after revascu-
larization of a tight stenosis. When coronary perfusion is
restored, the distension pressure increases, which in turn
might lead to an increase in the diameter of the vessel. In
addition, at the end of an angioplasty, several episodes of
balloon occlusion-induced ischemia/hyperemia cycles might
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645contribute to further endothelium-dependent epicardial va-
sodilation (5). Because the cross-sectional area of the artery
relates to the square of its radius, a small increase in
diameter might be accompanied by a marked decrease in
flow velocity at constant absolute flow.
“Slow flow” does not necessarily mean “low flow.”
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